Biomedical Textiles Market Report

Biomedical Textiles Market Report

Biomedical Textiles Market Report
Report code - SR3580 Delivery - 2 Weeks
Biomedical Textiles Market Size, Share, Trends, Forecast, Competitive Analysis, and Growth See more...

Market Insights

“The biomedical textiles market size was valued at US$ 18.2 billion in 2024 and is projected to reach US$ 27.9 billion, growing at a CAGR of 6.3% by 2031.”

Market Dynamics

Introduction

Biomedical textiles are specially engineered fabrics designed for use in medical and healthcare applications, offering properties such as biocompatibility, antimicrobial resistance, flexibility, and enhanced wound healing. These characteristics make them indispensable in products like wound dressings, surgical sutures, prosthetics, and implantable devices. Beyond serving as passive materials, modern biomedical textiles often actively support healing processes, deliver medications, or integrate with human tissue. The market for these textiles is growing steadily, driven by the increasing number of surgical procedures, the rapidly aging global population, and rising healthcare investments, particularly in developing regions. Technological advancements in textile design and manufacturing are further expanding their potential, making biomedical textiles a crucial component of modern medical care.

Segment Analysis

Segmentations

List of Sub-Segments

Segments with High-Growth Opportunity

Fiber-Type Analysis

Non-biodegradable Fibers and Biodegradable Fibers

Non-biodegradable fibres are expected to remain dominant due to their durability and wide usage.

Fabric-Type Analysis

Non-woven, Woven, and Others

Non-woven fabrics lead the market, especially in wound care and disposables, owing to cost and utility.

Application Analysis

Non-implantable, Surgical Sutures, and Others

Non-implantable textiles (wound dressings, bandages) will remain the largest and fastest-growing use.

Region Analysis

North America, Europe, Asia-Pacific, and The Rest of the World

Asia-Pacific is projected as the fastest-growing region, led by China and India’s healthcare expansion.


By Fiber Type

“Non-biodegradable fibres are expected to remain the dominant fiber type of the biomedical textiles market due to their superior durability and extensive use in both non-implantable and implantable medical products.

The market is segmented into non-biodegradable fibers and biodegradable fibers. Non-biodegradable fibres such as polyester, polypropylene, polyamides, cotton, viscose, and PTFE hold a dominant share, driven by their high-performance characteristics in both implantable and non-implantable products.

By Fabric Type

“Non-woven fabrics dominate the market, particularly in wound care and disposable applications, due to their cost-effectiveness and practical utility.”

The market is segmented into non-woven, woven, and others. Non-woven fabrics have become essential in the production of disposable medical products such as surgical gowns, masks, and drapes, largely due to their excellent absorption capacity, softness, flexibility, and cost-effectiveness. They offer superior barrier properties while remaining lightweight and breathable. However, woven and knitted fabrics continue to play a vital role in applications where higher mechanical strength, durability, or elasticity is required, such as in orthopaedic supports, vascular grafts, and implantable devices. The combination of these fabric types enables manufacturers to meet diverse clinical and performance demands across various medical applications.

By Application

“Non-implantable textiles, such as wound dressings and bandages, are expected to remain the largest and fastest-growing application categories.”

The market is segmented into non-implantable, surgical sutures, and others. Non-implantable textiles, including bandages, wound dressings, and orthopaedic support products, dominate the biomedical textiles market due to their widespread use in routine and post-surgical care. Their demand is fuelled by the rising number of surgeries and chronic wound cases globally. Meanwhile, the surgical sutures segment remains stable, supported by continuous product innovations aimed at improving biocompatibility and performance, as well as stringent regulatory standards that ensure quality and safety in surgical procedures.

Regional Analysis

North America leads due to the high adoption of advanced healthcare solutions, the presence of leading biomedical textile manufacturers, and significant healthcare R&D investments. China is the largest single-country market, benefiting from a strong industrial base and rapid healthcare sector growth. The Asia-Pacific region is projected as the fastest-growing, with China and India leading growth, propelled by increased healthcare investment and a large aging population.

Key Players

The market is fragmented, with over 100 players. Most of the major players compete in some of the governing factors, including price, service offerings, and regional presence, etc. The following are the key players in the biomedical textiles market.

  • Royal DSM
  • Johnson & Johnson
  • Medtronic
  • Cardinal Health
  • Integra LifeSciences Corporation
  • Smith & Nephew
  • Paul Hartmann AG
  • Mölnlycke Health Care
  • BSN Medical
  • Medline Industries
  • ATEX Technologies
  • 3M Company
  • Freudenberg & Co. Kommanditgesellschaf

Note: The above list does not necessarily include all the top players in the market.

Are you the leading player in this market? We would love to include your name. Please write to us at [email protected]

Report Features

This report provides market intelligence most comprehensively. The report structure has been kept so that it offers maximum business value. It provides critical insights into market dynamics and will enable strategic decision-making for existing market players as well as those willing to enter the market. The following are the key features of the report:

  • Market structure: Overview, industry life cycle analysis, supply chain analysis.
  • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis.
  • Market trend and forecast analysis.
  • Market segment trend and forecast.
  • Competitive landscape and dynamics: Market share, Service portfolio, New Product Launches, etc.
  • COVID-19 impact and its recovery curve.
  • Attractive market segments and associated growth opportunities.
  • Emerging trends.
  • Strategic growth opportunities for the existing and new players.
  • Key success factors.

The global Biomedical Textiles Market is segmented into the following categories. 

Biomedical Textiles market, by Fiber Type

  • Non-biodegradable (Regional Analysis: North America, Europe, Asia-Pacific, Rest of World)
  • Biodegradable (Regional Analysis: North America, Europe, Asia-Pacific, Rest of World)

Biomedical Textiles market by Fabric Type

  • Non-woven (Regional Analysis: North America, Europe, Asia-Pacific, Rest of World)
  • Woven (Regional Analysis: North America, Europe, Asia-Pacific, Rest of World)
  • Others (Regional Analysis: North America, Europe, Asia-Pacific, Rest of World)

Biomedical Textiles market by Application

  • Non-implantable (Regional Analysis: North America, Europe, Asia-Pacific, Rest of World)
  • Surgical sutures (Regional Analysis: North America, Europe, Asia-Pacific, Rest of World)
  • Others (Regional Analysis: North America, Europe, Asia-Pacific, Rest of World)

Biomedical Textiles Market by Region

  • North America (Country Analysis: The USA, Canada, and Mexico)
  • Europe (Country Analysis: Germany, France, The UK, Russia, and the Rest of Europe)
  • Asia-Pacific (Country Analysis: Japan, China, India, and Rest of Asia-Pacific)
  • Rest of the World (Country Analysis: Brazil, Saudi Arabia, and Others)

Research Methodology

  • This strategic assessment report from Stratview Research provides a comprehensive analysis that reflects today’s biomedical textiles market realities and future market possibilities for the forecast period.
  • The report segments and analyzes the market in the most detailed manner in order to provide a panoramic view of the market.
  • The vital data/information provided in the report can play a crucial role for market participants and investors in identifying the low-hanging fruit available in the market and formulating growth strategies to expedite their growth process.
  • This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.
  • More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data.
  • We conducted more than 15 detailed primary interviews with market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respected clients:

Company Profiling

  • Detailed profiling of additional market players (up to three players)
  • SWOT analysis of key players (up to three players)

Competitive Benchmarking

  • Benchmarking of key players on the following parameters: Service portfolio, geographical reach, regional presence, and strategic alliances

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected]

Non-woven fabrics, non-biodegradable fibres, and non-implantable applications.

North America, due to cutting-edge medical technology adoption, major player presence, and strong healthcare R&D.

Asia-Pacific, on account of rapid healthcare expansion and growing patient populations.

Advanced fabrics designed for medical use, offering biocompatibility, antimicrobial action, and application in wound care, surgical, and implantable devices.

Non-biodegradable fibres claim the largest market share.